MAP3K2 and hepatocellular carcinoma: The circBACH1/miR200a-3p/MAP3K2 axis influences the activities of both HBV and HCC, suggesting the potential of circBACH1 as a therapeutic target for simultaneously eliminating HBV cccDNAs and suppressing HBV-HCC development in patients with HBV-HCC.